Tofacitinib in Patients with Ulcerative Colitis: Inflammatory Bowel Disease Questionnaire Items in Phase 3 Randomized Controlled Induction Studies

BACKGROUND: Tofacitinib is an oral, small molecule Janus kinase inhibitor for the treatment of ulcerative colitis (UC). We examined the effect of tofacitinib induction treatment on Inflammatory Bowel Disease Questionnaire (IBDQ) items in adults with moderate to severe UC. METHODS: Data were pooled f...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Inflamm Bowel Dis
Main Authors: Dubinsky, Marla C, DiBonaventura, Marco, Fan, Haiyun, Bushmakin, Andrew G, Cappelleri, Joseph C, Maller, Eric, Thorpe, Andrew J, Salese, Leonardo, Panés, Julian
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Clinical Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8205629/
https://ncbi.nlm.nih.gov/pubmed/32794567
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ibd/izaa193
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados